Product Security Updates

{{searchText ? ' for "' : ''}}{{searchText}}{{searchText ? '"' : ''}}

End of Windows 7 Cybersecurity Support for GeneXpert® Systems

Updated June 30, 2023

 

BACKGROUND

 

Microsoft ended Windows 7 Operating System (OS) support in January 2020, discontinuing patches and updates. Consequently, Cepheid is no longer able to support the latest cybersecurity and privacy standards on Windows 7 OS computers. Your instrument software and current tests will continue to work with Windows 7 OS. However, as of June 30, 2023 all future GeneXpert Dx, Infinity Xpertise, or Xpert Check software releases (the GeneXpert systems) will not be compatible with Windows 7 OS.

 

For More Information, please see here

 

Log4Shell (Apache Log4j)

Updated July 8th, 2022

BACKGROUND

On December 10, 2021, a critical vulnerability (CVE-2021-44228) was reported in Apache Log4j. The
vulnerability impacts multiple versions of the Apache Log4j utility and the applications that use it. The
vulnerability allows an attacker to execute arbitrary code.

RESPONSE

Cepheid teams have successfully analyzed and addressed the potential security risk to our product portfolio, in the form of a revised software patch. Communication has been sent out to all the customers that may benefit from the software patch, outlining the process to request the patch. Customers are encouraged to request the patch for a more secure user experience.

Individuals or organizations with additional product security concerns are encouraged to contact their local Cepheid Technical support team at techsupport@cepheid.com or email productsecurity@cepheid.com

 

PrintNightmare Windows Print Spooler Remote Code Execution Vulnerability (CVE-2021-34527, CVE-2021-36947, CVE-2021-36936, CVE-2021-34483, CVE-2021-34481, CVE-2021-36958)

Updated Septemer 14th, 2021

BACKGROUND

On July 6th, 2021, Microsoft released a patch for a critical Remote Code Execution vulnerability to address CVE-2021-34527. The Microsoft Windows Print Spooler service fails to restrict access to functionality that allows users to add printers and related drivers, which can allow a remote authenticated attacker to execute arbitrary code with SYSTEM privileges on a vulnerable system. Since then, multiple CVE’s have been added as part of the combined “PrintNightmare” vulnerability, along with additional patches.

This vulnerability impacts all windows operating systems.

RESPONSE

Cepheid’s research and development teams are analyzing the Microsoft patches for CVE-2021-34527, CVE-2021-36947, CVE-2021-36936, CVE-2021-34483, CVE-2021-34481 for impact to affected products.

 

CryptoAPI

Updated January 20th, 2020

BACKGROUND

On January 14, 2020, Microsoft released patches to remediate 49 vulnerabilities within their monthly Patch Tuesday announcement. Amongst the available patches, is the vulnerability (CVE-2020-0601) affecting Microsoft Windows cryptographic functionality known as Windows CryptoAPI. The vulnerability affects GeneXpert systems running on Windows 10 Professional.

RESPONSE

Cepheid is aware of this identified vulnerability and is currently monitoring related developments. Cepheid has not received any reports of these vulnerabilities affecting the clinical use of our products and is evaluating the potential impact of the vulnerability on its products.

Cepheid has not yet confirmed compatibility of its GeneXpert systems with patches that mitigate CVE-2020-0601. The compatibility testing process is underway, and we expect it to be completed within the next several weeks.   

If you would like to be notified when compatibility testing is completed, please contact your local Cepheid Technical support team or email productsecurity@cepheid.com.

DejaBlue

September 13th, 2019

BACKGROUND

On August 13, 2019 Microsoft released a set of fixes for Remote Desktop Services that include two critical Remote Code Execution (RCE) vulnerabilities, CVE-2019-1181, CVE-2019-1182, CVE-2019-1222, and CVE-2019-1226. Like the previously-fixed ‘BlueKeep’ vulnerability (CVE-2019-0708), these two vulnerabilities are also ‘wormable’, meaning that any future malware that exploits these could propagate from vulnerable computer to vulnerable computer without user interaction.

The affected versions of Windows are Windows 7 SP1, Windows Server 2008 R2 SP1, Windows Server 2012, Windows 8.1, Windows Server 2012 R2, and all supported versions of Windows 10, including server versions.

Windows XP, Windows Server 2003, and Windows Server 2008 are not affected, nor is the Remote Desktop Protocol (RDP) itself affected.

RESPONSE

Cepheid has validated the installation of the following Microsoft patches for its GeneXpert systems and where appropriate, developed specific customer instructions for those systems. For detailed information on each Cepheid product, please see product list below.

If you have any questions, please contact your local Cepheid Technical support team or email productsecurity@cepheid.com.

Software Version Patch Location Additional Steps
GeneXpert Dx

https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1181
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1182
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1222
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1226

Install patch for your operating system and build Restart computer
Xpertise G1

https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1181
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1182
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1222
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1226

Install patch for your operating system and build Restart computer
Xpertise G2

https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1181
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1182
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1222
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1226

Install patch for your operating system and build Restart computer
GeneXpert Xpress

https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1181
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1182
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1222
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1226

Install patch for your operating system and build Restart computer
Cepheid Link

https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1181
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1182
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1222
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1226

Install patch for your operating system and build Restart computer
XpertCheck

https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1181
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1182
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1222
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-1226

Install patch for your operating system and build Restart computer

CVE-2019-0708 Remote Desktop Protocol Vulnerability (Bluekeep)

Updated July 25th, 2019

BACKGROUND

On May 15th, 2019, Microsoft released a patch for a critical Remote Code Execution vulnerability in Remote Desktop Services (CVE-2019-0708). CVE-2019-0708 is a vulnerability, not a virus. This vulnerability can be exploited remotely without authentication on systems that use Remote Desktop Services as part of Windows XP and Windows 7.

RESPONSE

Cepheid has validated the installation of the Microsoft patch for CVE-2019-0708 and where appropriate, developed specific customer instructions for those systems. For detailed information on each Cepheid product, please see products list below.

If you have any questions, please contact your local Cepheid Technical support team or email productsecurity@cepheid.com.

Product Line Patch Location Additional Steps
Dx SW

Win XP:  https://support.microsoft.com/en-us/help/4500705/customer-guidance-for-cve-2019-0708
Win 7:  https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-0708

Restart PC after installation of patch
Xpertise SW - G1 Win XP:  https://support.microsoft.com/en-us/help/4500705/customer-guidance-for-cve-2019-0708
Win 7:  https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-0708    
Restart PC after installation of patch
Xpertise SW - G2 Win XP:  https://support.microsoft.com/en-us/help/4500705/customer-guidance-for-cve-2019-0708
Win 7:  https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-0708    
Restart PC after installation of patch
Xpress Win XP:  https://support.microsoft.com/en-us/help/4500705/customer-guidance-for-cve-2019-0708
Win 7:  https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-0708    
Restart PC after installation of patch
ONCore Win XP:  https://support.microsoft.com/en-us/help/4500705/customer-guidance-for-cve-2019-0708
Win 7:  https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-0708    
Restart PC after installation of patch
Cepheid Link Win XP:  https://support.microsoft.com/en-us/help/4500705/customer-guidance-for-cve-2019-0708
Win 7:  https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-0708    
Restart PC after installation of patch
XpertCheck Win XP:  https://support.microsoft.com/en-us/help/4500705/customer-guidance-for-cve-2019-0708
Win 7:  https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2019-0708    
Restart PC after installation of patch

Updated June 13th, 2019

RESPONSE

Cepheid is aware of this identified vulnerability and is currently monitoring related developments. Cepheid has not received any reports of these vulnerabilities affecting the clinical use of our products and is evaluating the potential impact of the vulnerability on its products.

Cepheid has not yet confirmed compatibility of its GeneXpert systems with patches that mitigate CVE-2019-0708. The compatibility testing process is underway, and we expect it to be completed within the next several weeks.

If you would like to be notified when compatibility testing is completed, please contact your local Cepheid Technical support team or email productsecurity@cepheid.com